paeonol has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Guo, W; He, X; Li, J | 1 |
| Chen, L; Fu, B; Wang, X; Zhang, J; Zhang, X; Zhao, T; Zhao, Y | 1 |
2 other study(ies) available for paeonol and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Involvement of brain-gut axis in treatment of cerebral infarction by β-asaron and paeonol.
Topics: Acetophenones; Animals; Brain; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; NF-kappa B; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
Paeonol pretreatment attenuates cerebral ischemic injury via upregulating expression of pAkt, Nrf2, HO-1 and ameliorating BBB permeability in mice.
Topics: Acetophenones; Animals; Blood-Brain Barrier; Capillary Permeability; Claudin-5; Disease Models, Animal; Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Neuroprotective Agents; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-akt; Spectrum Analysis; Superoxide Dismutase; Up-Regulation | 2014 |